Sheetz is quitting VMware, migrating 11,000 virtua
2026年07月16日 05:417,543 次阅读
AI导读
Sheetz, a US convenience store chain, is moving its 838 locations off VMware.
Sheetz has used VMware virtualization across two Dell R440/R450-series servers at each of its locations since 2019. Now it’s migrating 12 to 14 virtual machines (VMs) in each of its stores from VMware vSphere to StorMagic’...
Sheetz, a US convenience store chain, is moving its 838 locations off VMware.
Sheetz has used VMware virtualization across two Dell R440/R450-series servers at each of its locations since 2019. Now it’s migrating 12 to 14 virtual machines (VMs) in each of its stores from VMware vSphere to StorMagic’s SvHCI, “with an additional two VMs to be replaced over the coming months to transition from Windows 10 to Windows 11,” Scott Robertson, infrastructure team manager at Sheetz, told Ars Technica via email. Ultimately, Sheetz will move about 11,000 VMs from Broadcom's virtualization platform. Sheetz is still running the original Dell server hardware.
So far, Sheetz has finished migrating more than 600 stores, averaging 200 per month, according to a company announcement today. Sheetz should be finished with the migration in four months, the announcement said.Read full article
Comments
The AI boom is becoming a materials challenge. As AI pushes computing into new territory, the materials behind that infrastructure are becoming just as crucial as the algorithms running on it. Semiconductors and data centers are approaching physical limits around performance, thermal management, ele...
Amazon today announced that its Alexa+ conversational assistant is available in India with Hindi support. The new assistant can hold conversations for longer and maintain context while doing so. The feature is available to all customers in the country in Early Access in Hindi and English. After the ...
When remotely operated vehicles settle on the seafloor or dig through a sand bed, they can kick up clouds of sediment that onboard cameras struggle to see through. Often, the only thing to do is wait until the dust settles. But a new system developed by Amy Phung, SM ’23, PhD ’26, and her advisor Ri...
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it...